首页 > 最新文献

Clinical Orthopaedics and Related Research®最新文献

英文 中文
Is RAGE Expression in Flexor Tendon Synovium Associated With Carpal Tunnel Syndrome in Patients With Diabetes? 糖尿病患者屈肌腱滑膜RAGE表达与腕管综合征相关吗?
IF 4.2 2区 医学 Q1 ORTHOPEDICS Pub Date : 2025-12-10 DOI: 10.1097/corr.0000000000003800
Dong Uk Jin,Ji Sup Hwang,Hyun Sik Gong
BACKGROUNDCarpal tunnel syndrome (CTS) is the most common entrapment neuropathy and is more prevalent in patients with diabetes. However, the underlying mechanisms linking diabetes and CTS have not been fully elucidated. The advanced glycation end products (AGEs) and the receptor for AGEs (RAGE) are involved in chronic inflammation and diabetic complications, suggesting that this pathway may be relevant to the pathogenesis of CTS in patients with diabetes.QUESTIONS/PURPOSES(1) Is RAGE expressed in the flexor tendon synovium in patients with CTS, and if so, is it expressed more in patients with diabetes? (2) Is RAGE expression in the flexor tendon synovium associated with CTS severity?METHODSBetween February 2020 and March 2023, a total of 130 patients underwent open carpal tunnel release performed by a single highly experienced hand surgeon. Patients with peripheral neuropathies, cervical radiculopathy, diabetic polyneuropathy, systemic inflammatory diseases such as gout or rheumatoid arthritis, a history of wrist fracture, or previous wrist surgery were excluded. Patients who did not consent to tissue storage or whose consent was not documented were also excluded. As a result, flexor tendon synovium samples were available in the biobank for 72% (93 patients) of the initial cohort. Among these, 8% (7 of 93) of samples were excluded because of poor immunohistochemical staining quality, leaving 66% (86 patients) of the initial cohort for the final analysis. The mean ± SD age of the patients was 60 ± 12 years. Of the 86 patients, 81% (70) were female. CTS severity was classified according to the Bland scale as mild to moderate (Grades 1 to 3) or severe (Grades 4 to 6) based on electrophysiologic findings. In this cohort, 45% (39) had severe CTS and 21% (18) had diabetes. RAGE expression in the flexor tendon synovium was measured semiquantitatively by immunohistochemistry. The scoring method showed excellent interobserver reliability (intraclass correlation coefficient 0.92). RAGE expression was compared between patients with and without diabetes. Multivariable logistic regression analysis was performed to identify factors that were independently related to CTS severity.RESULTSHistopathologic analysis revealed that RAGE expression was predominantly observed in the vascular endothelial cells of the subsynovial connective tissue. Patients with diabetes had a greater RAGE staining index expression than those without diabetes (median [IQR] 8.5 [6.0 to 9.0] versus 8.0 [6.0 to 8.0], difference of medians 0.5; p = 0.03). For all patients, those with and without diabetes, RAGE staining index expression was not associated with CTS severity (OR 1.17 [95% confidence interval (CI) 0.94 to 1.44]; p = 0.16), BMI was not associated (OR 1.12 [95% CI 0.98 to 1.29]; p = 0.10), and only age was associated (OR 1.10 [95% CI 1.05 to 1.17]; p < 0.001). When stratified to only those patients with diabetes, after controlling for potentially confounding variables such as age
背景:腕管综合征(carpal tunnel syndrome, CTS)是最常见的压迫性神经病变,在糖尿病患者中更为常见。然而,将糖尿病和CTS联系起来的潜在机制尚未完全阐明。晚期糖基化终产物(AGEs)和AGEs受体(RAGE)参与慢性炎症和糖尿病并发症,提示该途径可能与糖尿病患者CTS的发病机制有关。(1) RAGE是否在CTS患者的屈肌腱滑膜中表达,如果有,是否在糖尿病患者中表达更多?(2)屈肌腱滑膜RAGE表达是否与CTS严重程度相关?方法:在2020年2月至2023年3月期间,共有130例患者接受了由一位经验丰富的手外科医生实施的开放式腕管松解术。排除有周围神经病变、颈神经根病、糖尿病多发性神经病变、全身炎性疾病如痛风或类风湿关节炎、腕部骨折史或既往腕部手术的患者。不同意组织储存或没有书面同意的患者也被排除在外。结果,初始队列中72%(93例)的屈肌腱滑膜样本在生物库中可用。其中,由于免疫组化染色质量差,有8%(93例中的7例)的样本被排除,留下66%(86例)的初始队列进行最终分析。患者平均±SD年龄为60±12岁。86例患者中,81%(70例)为女性。根据电生理结果,CTS的严重程度根据Bland量表分为轻度至中度(1至3级)或重度(4至6级)。在该队列中,45%(39人)患有严重CTS, 21%(18人)患有糖尿病。采用免疫组化半定量法检测RAGE在屈肌腱滑膜中的表达。评分方法具有良好的观察者间信度(类内相关系数0.92)。比较糖尿病患者和非糖尿病患者的RAGE表达。进行多变量logistic回归分析,以确定与CTS严重程度独立相关的因素。结果组织病理学分析显示RAGE主要表达于滑膜下结缔组织血管内皮细胞。糖尿病患者RAGE染色指数表达高于无糖尿病患者(中位数[IQR] 8.5[6.0 ~ 9.0]对8.0[6.0 ~ 8.0],中位数差异0.5;p = 0.03)。对于所有患者,无论是否患有糖尿病,RAGE染色指数的表达与CTS严重程度无关(OR 1.17[95%可信区间(CI) 0.94至1.44];p = 0.16), BMI无关(OR 1.12 [95% CI 0.98 ~ 1.29]; p = 0.10),只有年龄相关(OR 1.10 [95% CI 1.05 ~ 1.17]; p < 0.001)。当只对糖尿病患者进行分层时,在控制了年龄、BMI等潜在的混杂变量后,在我们研究的变量中,只有RAGE染色指数表达与CTS相关(OR 3.40 [95% CI 1.10 ~ 10.53]; p = 0.03),这是本研究的关键发现。结论rage介导的机制可能参与糖尿病相关CTS的病理生理机制。需要进一步的研究来阐明RAGE相关的分子通路,并确定靶向RAGE是否可能成为影响疾病进展或手术结果的潜在治疗策略。证据等级:诊断性研究III级。
{"title":"Is RAGE Expression in Flexor Tendon Synovium Associated With Carpal Tunnel Syndrome in Patients With Diabetes?","authors":"Dong Uk Jin,Ji Sup Hwang,Hyun Sik Gong","doi":"10.1097/corr.0000000000003800","DOIUrl":"https://doi.org/10.1097/corr.0000000000003800","url":null,"abstract":"BACKGROUNDCarpal tunnel syndrome (CTS) is the most common entrapment neuropathy and is more prevalent in patients with diabetes. However, the underlying mechanisms linking diabetes and CTS have not been fully elucidated. The advanced glycation end products (AGEs) and the receptor for AGEs (RAGE) are involved in chronic inflammation and diabetic complications, suggesting that this pathway may be relevant to the pathogenesis of CTS in patients with diabetes.QUESTIONS/PURPOSES(1) Is RAGE expressed in the flexor tendon synovium in patients with CTS, and if so, is it expressed more in patients with diabetes? (2) Is RAGE expression in the flexor tendon synovium associated with CTS severity?METHODSBetween February 2020 and March 2023, a total of 130 patients underwent open carpal tunnel release performed by a single highly experienced hand surgeon. Patients with peripheral neuropathies, cervical radiculopathy, diabetic polyneuropathy, systemic inflammatory diseases such as gout or rheumatoid arthritis, a history of wrist fracture, or previous wrist surgery were excluded. Patients who did not consent to tissue storage or whose consent was not documented were also excluded. As a result, flexor tendon synovium samples were available in the biobank for 72% (93 patients) of the initial cohort. Among these, 8% (7 of 93) of samples were excluded because of poor immunohistochemical staining quality, leaving 66% (86 patients) of the initial cohort for the final analysis. The mean ± SD age of the patients was 60 ± 12 years. Of the 86 patients, 81% (70) were female. CTS severity was classified according to the Bland scale as mild to moderate (Grades 1 to 3) or severe (Grades 4 to 6) based on electrophysiologic findings. In this cohort, 45% (39) had severe CTS and 21% (18) had diabetes. RAGE expression in the flexor tendon synovium was measured semiquantitatively by immunohistochemistry. The scoring method showed excellent interobserver reliability (intraclass correlation coefficient 0.92). RAGE expression was compared between patients with and without diabetes. Multivariable logistic regression analysis was performed to identify factors that were independently related to CTS severity.RESULTSHistopathologic analysis revealed that RAGE expression was predominantly observed in the vascular endothelial cells of the subsynovial connective tissue. Patients with diabetes had a greater RAGE staining index expression than those without diabetes (median [IQR] 8.5 [6.0 to 9.0] versus 8.0 [6.0 to 8.0], difference of medians 0.5; p = 0.03). For all patients, those with and without diabetes, RAGE staining index expression was not associated with CTS severity (OR 1.17 [95% confidence interval (CI) 0.94 to 1.44]; p = 0.16), BMI was not associated (OR 1.12 [95% CI 0.98 to 1.29]; p = 0.10), and only age was associated (OR 1.10 [95% CI 1.05 to 1.17]; p &lt; 0.001). When stratified to only those patients with diabetes, after controlling for potentially confounding variables such as age ","PeriodicalId":10404,"journal":{"name":"Clinical Orthopaedics and Related Research®","volume":"55 1","pages":""},"PeriodicalIF":4.2,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145711019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preliminary Surgical Findings and Complications After National Centralization of Pediatric Bone Sarcoma Resections in the Netherlands: A Benchmarking Study. 荷兰儿童骨肉瘤全国集中切除后的初步手术结果和并发症:一项基准研究。
IF 4.2 2区 医学 Q1 ORTHOPEDICS Pub Date : 2025-12-10 DOI: 10.1097/corr.0000000000003782
Lorenz H M van Schalkwijk,Jasper M van der Zee,Roelof van Ewijk,Johannes H M Merks,Jos A M Bramer,Hendrik W B Schreuder,Lianne M Haveman,Michiel A J van de Sande,Lizz van der Heijden
BACKGROUNDPediatric bone sarcomas are rare malignancies that are usually treated with specialized multimodal care to allow specialized oncologists to gain experience and provide expertise in treatment. In the Netherlands, oncologic care for all pediatric cancers, including pediatric bone sarcoma, has been centralized in one tertiary referral center for pediatric oncology since 2018. Surgical decision-making is not solely driven by whether limb salvage is oncologically feasible, but rather by a comprehensive shared decision-making process in which all surgical options are carefully weighed against one another. This includes not only oncologic safety, but also expected functional outcomes such as sports participation, the risk of complications, and the burden of additional surgeries that may be performed over time. By openly discussing these trade-offs with patients and families, we aim to reach a decision that best aligns with the family's values and expectations, and thereby with the child's long-term well-being and priorities. The objective of this study was to provide benchmark values for future comparisons of short-term perioperative and postoperative outcomes.QUESTIONS/PURPOSESWe evaluated results following the national centralization of pediatric bone sarcoma care in the Netherlands to determine: (1) What were the intraoperative complications and blood loss? (2) What was the proportion of patients who achieved R0 margins? (3) What were the 30- and 90-day complications after surgical treatment, and what proportion had a delay in resuming chemotherapy?METHODSBetween 2018 and 2024, a total of 157 children age 0 to 18 years underwent surgical resection for primary malignant bone sarcoma. We excluded 42 patients who had centralized systemic treatment but underwent surgery at referring adult sarcoma centers and 16 patients who had an axial localization. We included 99 patients who underwent surgery at the national pediatric oncology center for osteosarcoma (n = 69), Ewing sarcoma (n = 25), or other (n = 5); the extremities were involved in most patients (91% [90]). Of these, none were lost to follow-up; 1% (1) died within the first year from other causes. Seventy percent (69 of 99) had ≥ 1 year of follow-up. Ninety-day postoperative outcomes were evaluated to capture clinically relevant short-term treatment morbidity and care continuity. Tumor and treatment characteristics were retrospectively analyzed. The median (IQR) age was 13 years (9 to 15); 36% (36) were female. The median (IQR) follow-up time was 18 months (8 to 43). Among the 99 included patients, surgical procedures included limb-sparing surgery (68% [67]), amputation (15% [15]), rotationplasty (17% [17]), and other (1% [1]). Medical charts were reviewed for blood loss and surgical margins. Postoperative complications (using the Clavien-Dindo and the Henderson classifications) are reported from short-term (< 30 days) to midterm (< 90 days).RESULTSThree percent (3 of 99) of patients had s
背景:儿童骨肉瘤是一种罕见的恶性肿瘤,通常采用专业的多模式治疗,以使专业的肿瘤学家获得治疗经验并提供专业知识。在荷兰,自2018年以来,包括小儿骨肉瘤在内的所有儿科癌症的肿瘤治疗都集中在一个儿科肿瘤三级转诊中心。手术决策不仅仅是由肢体保留在肿瘤上是否可行驱动的,而是由一个全面的共同决策过程驱动的,在这个过程中,所有的手术选择都是仔细权衡的。这不仅包括肿瘤安全性,还包括预期的功能结果,如运动参与,并发症的风险,以及随着时间的推移可能进行的额外手术的负担。通过与患者和家属公开讨论这些权衡,我们的目标是达成一个最符合家庭价值观和期望的决定,从而符合孩子的长期福祉和优先事项。本研究的目的是为将来短期围手术期和术后结果的比较提供基准值。问题/目的:我们评估了荷兰儿童骨肉瘤全国集中治疗后的结果,以确定:(1)术中并发症和出血量是什么?(2)达到R0边际的患者比例是多少?(3)手术治疗后30天和90天的并发症是什么,延迟恢复化疗的比例是多少?方法:2018年至2024年间,共有157名0至18岁的儿童接受了原发性恶性骨肉瘤手术切除。我们排除了42例接受集中全身治疗但在转诊成人肉瘤中心接受手术的患者和16例轴向定位的患者。我们纳入了99例在国家儿童肿瘤中心因骨肉瘤(n = 69)、尤文氏肉瘤(n = 25)或其他(n = 5)而接受手术的患者;大多数患者(91%[90])累及四肢。其中,没有人因随访而丢失;1%(1)在第一年内死于其他原因。70%(69 / 99)患者随访≥1年。对术后90天的结果进行评估,以获取临床相关的短期治疗发病率和护理连续性。回顾性分析肿瘤及治疗特点。中位(IQR)年龄为13岁(9 ~ 15岁);36%(36例)为女性。中位(IQR)随访时间为18个月(8 ~ 43)。在纳入的99例患者中,手术方式包括保肢手术(68%[67])、截肢(15%[15])、旋转成形术(17%[15])和其他(1%[1])。我们回顾了失血和手术边缘的病历。术后并发症(使用Clavien-Dindo和Henderson分类)从短期(< 30天)到中期(< 90天)报道。结果99例患者中有3例(3%)出现严重的术中并发症,出血量中位数(范围)为100 mL(50 ~ 4000)。94%(93)的患者实现了R0边缘。22%(22)的患者在术后30天内出现任何并发症(感染、伤口裂开、压疮、骨折、神经血管),11%(11)的患者因并发症再次手术。最常见的并发症是感染和/或伤口裂开(11%);发生一例骨折。术后化疗的中位(IQR)时间为18天(16 ~ 22天)。7%(7)的患者因并发症在术后28天内开始化疗。在第90天,假体关节感染(Henderson 4a型)通过清创、抗生素和种植体保留(DAIR)(4%[2])或两阶段翻修(2%[2])进行治疗。结论虽然并发症较多,但很少延误术后化疗。尽量减少术后并发症可能有助于改善治疗的连续性和效果。在国家集中护理之后,这一初步基准为未来研究中评估手术效果提供了有临床意义的围手术期和术后结果指标;术后晚期并发症和肿瘤预后将在随访时间延长后报告。证据等级:III级,治疗性研究。
{"title":"Preliminary Surgical Findings and Complications After National Centralization of Pediatric Bone Sarcoma Resections in the Netherlands: A Benchmarking Study.","authors":"Lorenz H M van Schalkwijk,Jasper M van der Zee,Roelof van Ewijk,Johannes H M Merks,Jos A M Bramer,Hendrik W B Schreuder,Lianne M Haveman,Michiel A J van de Sande,Lizz van der Heijden","doi":"10.1097/corr.0000000000003782","DOIUrl":"https://doi.org/10.1097/corr.0000000000003782","url":null,"abstract":"BACKGROUNDPediatric bone sarcomas are rare malignancies that are usually treated with specialized multimodal care to allow specialized oncologists to gain experience and provide expertise in treatment. In the Netherlands, oncologic care for all pediatric cancers, including pediatric bone sarcoma, has been centralized in one tertiary referral center for pediatric oncology since 2018. Surgical decision-making is not solely driven by whether limb salvage is oncologically feasible, but rather by a comprehensive shared decision-making process in which all surgical options are carefully weighed against one another. This includes not only oncologic safety, but also expected functional outcomes such as sports participation, the risk of complications, and the burden of additional surgeries that may be performed over time. By openly discussing these trade-offs with patients and families, we aim to reach a decision that best aligns with the family's values and expectations, and thereby with the child's long-term well-being and priorities. The objective of this study was to provide benchmark values for future comparisons of short-term perioperative and postoperative outcomes.QUESTIONS/PURPOSESWe evaluated results following the national centralization of pediatric bone sarcoma care in the Netherlands to determine: (1) What were the intraoperative complications and blood loss? (2) What was the proportion of patients who achieved R0 margins? (3) What were the 30- and 90-day complications after surgical treatment, and what proportion had a delay in resuming chemotherapy?METHODSBetween 2018 and 2024, a total of 157 children age 0 to 18 years underwent surgical resection for primary malignant bone sarcoma. We excluded 42 patients who had centralized systemic treatment but underwent surgery at referring adult sarcoma centers and 16 patients who had an axial localization. We included 99 patients who underwent surgery at the national pediatric oncology center for osteosarcoma (n = 69), Ewing sarcoma (n = 25), or other (n = 5); the extremities were involved in most patients (91% [90]). Of these, none were lost to follow-up; 1% (1) died within the first year from other causes. Seventy percent (69 of 99) had ≥ 1 year of follow-up. Ninety-day postoperative outcomes were evaluated to capture clinically relevant short-term treatment morbidity and care continuity. Tumor and treatment characteristics were retrospectively analyzed. The median (IQR) age was 13 years (9 to 15); 36% (36) were female. The median (IQR) follow-up time was 18 months (8 to 43). Among the 99 included patients, surgical procedures included limb-sparing surgery (68% [67]), amputation (15% [15]), rotationplasty (17% [17]), and other (1% [1]). Medical charts were reviewed for blood loss and surgical margins. Postoperative complications (using the Clavien-Dindo and the Henderson classifications) are reported from short-term (&lt; 30 days) to midterm (&lt; 90 days).RESULTSThree percent (3 of 99) of patients had s","PeriodicalId":10404,"journal":{"name":"Clinical Orthopaedics and Related Research®","volume":"6 1","pages":""},"PeriodicalIF":4.2,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145777470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Residency Diary: Getting Stuck In. 住院医师日记:陷入困境。
IF 4.4 2区 医学 Q1 ORTHOPEDICS Pub Date : 2025-12-10 DOI: 10.1097/CORR.0000000000003794
Lisa G M Friedman
{"title":"Residency Diary: Getting Stuck In.","authors":"Lisa G M Friedman","doi":"10.1097/CORR.0000000000003794","DOIUrl":"10.1097/CORR.0000000000003794","url":null,"abstract":"","PeriodicalId":10404,"journal":{"name":"Clinical Orthopaedics and Related Research®","volume":" ","pages":""},"PeriodicalIF":4.4,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145767309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CORR Insights®: Does Isolated Ankle Arthrodesis Affect Medial Column Alignment in Patients With Progressive Collapsing Foot Deformity and End-stage Ankle Osteoarthritis? CORR Insights®:孤立踝关节融合术是否会影响进行性塌陷足畸形和终末期踝关节骨性关节炎患者的内侧柱对齐?
IF 4.4 2区 医学 Q1 ORTHOPEDICS Pub Date : 2025-12-10 DOI: 10.1097/CORR.0000000000003801
Alexander S Rascoe
{"title":"CORR Insights®: Does Isolated Ankle Arthrodesis Affect Medial Column Alignment in Patients With Progressive Collapsing Foot Deformity and End-stage Ankle Osteoarthritis?","authors":"Alexander S Rascoe","doi":"10.1097/CORR.0000000000003801","DOIUrl":"https://doi.org/10.1097/CORR.0000000000003801","url":null,"abstract":"","PeriodicalId":10404,"journal":{"name":"Clinical Orthopaedics and Related Research®","volume":" ","pages":""},"PeriodicalIF":4.4,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145767245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Value-based Healthcare: Shared Patients, Shared Risk-A Call for Integrating Primary and Musculoskeletal Care. 基于价值的医疗保健:共享患者,共享风险——对初级和肌肉骨骼护理整合的呼吁。
IF 4.2 2区 医学 Q1 ORTHOPEDICS Pub Date : 2025-12-09 DOI: 10.1097/corr.0000000000003793
Isabella Rubin,Adam Beckman,Kevin J Bozic
{"title":"Value-based Healthcare: Shared Patients, Shared Risk-A Call for Integrating Primary and Musculoskeletal Care.","authors":"Isabella Rubin,Adam Beckman,Kevin J Bozic","doi":"10.1097/corr.0000000000003793","DOIUrl":"https://doi.org/10.1097/corr.0000000000003793","url":null,"abstract":"","PeriodicalId":10404,"journal":{"name":"Clinical Orthopaedics and Related Research®","volume":"22 1","pages":""},"PeriodicalIF":4.2,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145711064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor: Factors That Increase the Risk of Prosthetic Joint Infection Within 90 Days After THA and TKA: A Nationwide Population-based Study. 致编辑的信:THA和TKA术后90天内增加假体关节感染风险的因素:一项基于全国人群的研究。
IF 4.2 2区 医学 Q1 ORTHOPEDICS Pub Date : 2025-12-08 DOI: 10.1097/corr.0000000000003797
Szu-An Jou,Chia-Hao Hsu
{"title":"Letter to the Editor: Factors That Increase the Risk of Prosthetic Joint Infection Within 90 Days After THA and TKA: A Nationwide Population-based Study.","authors":"Szu-An Jou,Chia-Hao Hsu","doi":"10.1097/corr.0000000000003797","DOIUrl":"https://doi.org/10.1097/corr.0000000000003797","url":null,"abstract":"","PeriodicalId":10404,"journal":{"name":"Clinical Orthopaedics and Related Research®","volume":"50 1","pages":""},"PeriodicalIF":4.2,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145777471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CORR Insights®: Is There a Relationship Between Social Health and Musculoskeletal Discomfort and Incapability? A Systematic Review. CORR洞察®:社会健康与肌肉骨骼不适和残疾之间是否存在关系?系统评价。
IF 4.2 2区 医学 Q1 ORTHOPEDICS Pub Date : 2025-12-03 DOI: 10.1097/corr.0000000000003759
Alicia R Jacobson
{"title":"CORR Insights®: Is There a Relationship Between Social Health and Musculoskeletal Discomfort and Incapability? A Systematic Review.","authors":"Alicia R Jacobson","doi":"10.1097/corr.0000000000003759","DOIUrl":"https://doi.org/10.1097/corr.0000000000003759","url":null,"abstract":"","PeriodicalId":10404,"journal":{"name":"Clinical Orthopaedics and Related Research®","volume":"14 1","pages":""},"PeriodicalIF":4.2,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145847533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond the Bone: From Healers to Enablers of Mobility. 超越骨骼:从治疗者到行动的推动者。
IF 4.2 2区 医学 Q1 ORTHOPEDICS Pub Date : 2025-12-02 DOI: 10.1097/corr.0000000000003783
Tae Kyun Kim
{"title":"Beyond the Bone: From Healers to Enablers of Mobility.","authors":"Tae Kyun Kim","doi":"10.1097/corr.0000000000003783","DOIUrl":"https://doi.org/10.1097/corr.0000000000003783","url":null,"abstract":"","PeriodicalId":10404,"journal":{"name":"Clinical Orthopaedics and Related Research®","volume":"4 1","pages":"20-22"},"PeriodicalIF":4.2,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145785829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CORR Synthesis: What Is the Role of Robotic Technology in THA? CORR综合:机器人技术在THA中的作用是什么?
IF 4.2 2区 医学 Q1 ORTHOPEDICS Pub Date : 2025-12-02 DOI: 10.1097/corr.0000000000003790
Ruby Lawson,Babar Kayani,John A Skinner
{"title":"CORR Synthesis: What Is the Role of Robotic Technology in THA?","authors":"Ruby Lawson,Babar Kayani,John A Skinner","doi":"10.1097/corr.0000000000003790","DOIUrl":"https://doi.org/10.1097/corr.0000000000003790","url":null,"abstract":"","PeriodicalId":10404,"journal":{"name":"Clinical Orthopaedics and Related Research®","volume":"28 1","pages":""},"PeriodicalIF":4.2,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145711021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor: A Conversation With … William Berloni, Broadway and Hollywood Animal Trainer, on the Differences Between Training and Education. 给编辑的信:与百老汇和好莱坞动物驯兽师威廉·伯洛尼的对话,关于训练和教育的区别。
IF 4.2 2区 医学 Q1 ORTHOPEDICS Pub Date : 2025-12-02 DOI: 10.1097/corr.0000000000003787
Safak Ekinci
{"title":"Letter to the Editor: A Conversation With … William Berloni, Broadway and Hollywood Animal Trainer, on the Differences Between Training and Education.","authors":"Safak Ekinci","doi":"10.1097/corr.0000000000003787","DOIUrl":"https://doi.org/10.1097/corr.0000000000003787","url":null,"abstract":"","PeriodicalId":10404,"journal":{"name":"Clinical Orthopaedics and Related Research®","volume":"29 1","pages":""},"PeriodicalIF":4.2,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145711020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Orthopaedics and Related Research®
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1